Search Results - "Nübling, Micha"

Refine Results
  1. 1
  2. 2

    WHO international standard for anti-rubella: learning from its application by Kempster, Sarah L, Almond, Neil, Dimech, Wayne, Grangeot-Keros, Liliane, Huzly, Daniela, Icenogle, Joseph, El Mubarak, Haja Sittana, Mulders, Mick N, Nübling, C Micha

    Published in The Lancet infectious diseases (01-01-2020)
    “…The WHO international standard for anti-rubella was first established in the 1960s when clinical diagnostics were in their infancy. Since the endorsement of…”
    Get full text
    Journal Article
  3. 3

    Standardization of Hepatitis E Virus (HEV) Nucleic Acid Amplification Technique-Based Assays: an Initial Study To Evaluate a Panel of HEV Strains and Investigate Laboratory Performance by BAYLIS, Sally A, HANSCHMANN, Kay-Martin, BLÜMEL, Johannes, MICHA NÜBLING, C

    Published in Journal of Clinical Microbiology (01-04-2011)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  4. 4

    Viral nucleic acids in human plasma pools by Zhang, Wen, Li, Linlin, Deng, Xutao, Blümel, Johannes, Nübling, C. Micha, Hunfeld, Andreas, Baylis, Sally A., Delwart, Eric

    Published in Transfusion (Philadelphia, Pa.) (01-09-2016)
    “…BACKGROUND The identification of viruses in human blood is required for epidemiologic surveillance and to detect potentially emerging threats to blood…”
    Get full text
    Journal Article
  5. 5

    Roadmap for Harmonization of Clinical Laboratory Measurement Procedures by GREG MILLER, W, MYERS, Gary L, MICHA NÜBLING, C, STURGEON, Catharine M, LOU GANTZER, Mary, KAHN, Stephen E, RALF SCHÖNBRUNNER, E, THIENPONT, Linda M, BUNK, David M, CHRISTENSON, Robert H, ECKFELDT, John H, LO, Stanley F

    Published in Clinical chemistry (Baltimore, Md.) (01-08-2011)
    “…Results between different clinical laboratory measurement procedures (CLMP) should be equivalent, within clinically meaningful limits, to enable optimal use of…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Hepatitis E viral loads in plasma pools for fractionation by Baylis, Sally A., Corman, Victor M., Ong, Edgar, Linnen, Jeffrey M., Nübling, C. Micha, Blümel, Johannes

    Published in Transfusion (Philadelphia, Pa.) (01-10-2016)
    “…BACKGROUND It is now recognized that blood donors may be silently infected with hepatitis E virus (HEV) and that plasma pools used in the manufacture of…”
    Get full text
    Journal Article
  9. 9

    Regulation of blood-screening in vitro diagnostics in sub-Saharan African countries remains a challenge by Abdurrahman, Goran, Samukange, Washington, Lyoko, Nyambe, Shonhiwa, Negus Onai, Kafere, Chancelar, Nübling, C. Micha, Peeling, Rosanna W., Reinhardt, Jens

    Published in Frontiers in medicine (03-10-2023)
    “…According to the World Health Organization, blood must be screened for major transmitted infections before transfusion to prevent the possibility of passing an…”
    Get full text
    Journal Article
  10. 10

    Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions by Nübling, C. Micha, Heiden, Margarethe, Chudy, Michael, Kress, Julia, Seitz, Rainer, Keller-Stanislawski, Brigitte, Funk, Markus B.

    Published in Transfusion (Philadelphia, Pa.) (01-09-2009)
    “…BACKGROUND: Mandatory nucleic acid test (NAT) blood screening was introduced in Germany in 1999 for hepatitis C virus (HCV) RNA and in 2004 for human…”
    Get full text
    Journal Article
  11. 11

    Standardization of NAT for Blood-Borne Pathogens by Baylis, Sally A., Chudy, Michael, Nübling, C. Micha

    Published in Transfusion medicine and hemotherapy (01-07-2015)
    “…Assays based on nucleic acid amplification technology (NAT) are increasingly used for screening of blood and for diagnosis or monitoring of patients. Both…”
    Get full text
    Journal Article
  12. 12

    How safe is safe: new human immunodeficiency virus Type 1 variants missed by nucleic acid testing by Müller, Benjamin, Nübling, C. Micha, Kress, Julia, Roth, W. Kurt, De Zolt, Silke, Pichl, Lutz

    Published in Transfusion (Philadelphia, Pa.) (01-10-2013)
    “…Background Nucleic acid amplification techniques (NAT) in routine blood donor screening considerably reduce the diagnostic window phase period. Nevertheless,…”
    Get full text
    Journal Article
  13. 13

    In vitro diagnostics for screening the blood supply: the new European regulation for IVD and the WHO IVD prequalification programme by Mbunkah, Herbert Afegenwi, Reinhardt, Jens, Kafere, Chancelar, Scheiblauer, Heiner, Prat, Irena, Nübling, Claudius Micha

    Published in Vox sanguinis (01-01-2021)
    “…Blood transfusion remains a routine life‐saving medical procedure that helps replace blood lost due to surgery, injury or disease. The quality of transfused…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase by Nübling, C. Micha, Unger, Gabriele, Chudy, Michael, Raia, Steven, Löwer, Johannes

    Published in Transfusion (Philadelphia, Pa.) (01-08-2002)
    “…BACKGROUND : Various countries have introduced HCV NAT to exclude infectious donations collected during the preseroconversion window phase (PWP). For the same…”
    Get full text
    Journal Article
  16. 16

    West Nile virus and blood product safety in Germany by Pfleiderer, Christa, Blümel, Johannes, Schmidt, Michael, Roth, W. Kurth, Houfar, M. Kai, Eckert, Jana, Chudy, Michael, Menichetti, Eva, Lechner, Sigrid, Nübling, C. Micha

    Published in Journal of medical virology (01-03-2008)
    “…West Nile Virus (WNV) is a mosquito-transmitted flavivirus, widely distributed throughout Africa, Asia and the Middle East. WNV may cause epidemics of human…”
    Get full text
    Journal Article
  17. 17
  18. 18

    World Health Organization International Standard to harmonize assays for detection of hepatitis E virus RNA by Baylis, Sally A, Blümel, Johannes, Mizusawa, Saeko, Matsubayashi, Keiji, Sakata, Hidekatsu, Okada, Yoshiaki, Nübling, C Micha, Hanschmann, Kay-Martin O

    Published in Emerging infectious diseases (01-05-2013)
    “…Nucleic acid amplification technique-based assays are a primary method for the detection of acute hepatitis E virus (HEV) infection, but assay sensitivity can…”
    Get full text
    Journal Article
  19. 19

    Hepatitis B virus genotype G monoinfection and its transmission by blood components by Chudy, Michael, Schmidt, Michael, Czudai, Volker, Scheiblauer, Heinrich, Nick, Sigrid, Mosebach, Mira, Hourfar, Michael Kai, Seifried, Erhard, Roth, W. Kurt, Grünelt, Elke, Nübling, C. Micha

    Published in Hepatology (Baltimore, Md.) (01-07-2006)
    “…An acute hepatitis B virus (HBV) infection was diagnosed in a regular apheresis (plasma/platelet) donor by the hepatitis B surface antigen (HBsAg) assay and…”
    Get full text
    Journal Article
  20. 20

    Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection by Nübling, C. Micha, Chudy, Michael, Volkers, Peter, Löwer, Johannes

    Published in Transfusion (Philadelphia, Pa.) (01-11-2006)
    “…BACKGROUND: A study was conducted to assess the diagnostic sensitivity of neopterin screening of blood donors with regard to the detection of window‐phase…”
    Get full text
    Journal Article